4//SEC Filing
Henrich Jill 4
Accession 0000905148-24-000907
CIK 0001604464other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 6:16 PM ET
Size
5.0 KB
Accession
0000905148-24-000907
Insider Transaction Report
Form 4
Henrich Jill
EVP, Chief Regulatory Officer
Transactions
- Sale
Common Stock
2024-03-04$0.72/sh−3,879$2,793→ 555,001 total
Footnotes (2)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 4, 2024 and March 5, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001978096
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 6:16 PM ET
- Size
- 5.0 KB